N6-Methylation Modification: Its Role in Regulating Cell Senescence and Inflammation in Osteoarthritis and Intervertebral Disc Degeneration
DNA and Cell Biology · 2026
DOI: 10.1177/10445498251411282 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, 2026. Verfasst von Rui Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Cellular Senescence, Osteoarthritis, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: the Jiangsu Provincial medical Key Discipline (Laboratory) Cultivation Unit, Open Project Programme of the Key Base for Standardized Training for General Physicans, Zhongda Hospital, Southeast University, Research Personnel Cultivation Programme of Zhongda Hospital Southeast University.
Abstract (Originalsprache)
N6-methyladenosine (m6A) methylation, the most prevalent internal mRNA modification in eukaryotes, plays a crucial role in regulating various biological processes. Recent advancements reveal its significant involvement in osteoarthritis (OA) and intervertebral disc degeneration (IVDD). m6A modifications influence key cellular processes such as inflammation, stress responses, and matrix homeostasis, which are pivotal in OA and IVDD pathogenesis. In OA, m6A methylation affects inflammatory responses, macrophage polarization, and chondrocyte ferroptosis, while in IVDD, it regulates RNA methylation and matrix integrity. Additionally, m6A interacts with noncoding RNAs, impacting their stability and function, thus influencing disease outcomes. Emerging evidence suggests that targeting m6A pathways could provide novel therapeutic strategies for managing OA and IVDD. Further research into m6A’s role in these diseases may reveal new biomarkers and therapeutic targets, offering potential for more effective treatments and improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.
- School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.
Förderung
- the Jiangsu Provincial medical Key Discipline (Laboratory) Cultivation Unit
- Open Project Programme of the Key Base for Standardized Training for General Physicans, Zhongda Hospital, Southeast University
- Research Personnel Cultivation Programme of Zhongda Hospital Southeast University
- Zhongda Hospital Affiliated to Southeast University, Jiangsu Province High-Level Hospital Construction Funds
- National Natural Science Foundation of China
- the Fundamental Research Funds for the Central Universities
- Jiangsu Entrepreneurship and Innovation Doctors
- Nanjing Health Science and Technology Development Special Fund Project
Zitieren
APA
Sun, R., Zhou, Y., Wu, X. T., Shi, H., Wang, F., Gao, J. W., Wang, P. Y., Xu, Z. Y., & Zhang, C. (2026). N6-Methylation Modification: Its Role in Regulating Cell Senescence and Inflammation in Osteoarthritis and Intervertebral Disc Degeneration. DNA and Cell Biology. https://doi.org/10.1177/10445498251411282
Vancouver
Sun R, Zhou Y, Wu XT, Shi H, Wang F, Gao JW, et al. N6-Methylation Modification: Its Role in Regulating Cell Senescence and Inflammation in Osteoarthritis and Intervertebral Disc Degeneration. DNA and Cell Biology. 2026. doi:10.1177/10445498251411282
BibTeX
@article{Sun2026,
author = {Sun, Rui and Zhou, Yan and Wu, Xiao-Tao and Shi, Hang and Wang, Feng and Gao, Jia-Wei and Wang, Pei-Yang and Xu, Zheng-Yuan and Zhang, Cong},
title = {N6-Methylation Modification: Its Role in Regulating Cell Senescence and Inflammation in Osteoarthritis and Intervertebral Disc Degeneration},
journal = {DNA and Cell Biology},
year = {2026},
doi = {10.1177/10445498251411282}
}
EUVIMED